These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 8772754)

  • 21. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure.
    Maeda K; Tsutamoto T; Wada A; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Sawaki M; Fujii M; Matsumoto T; Kinoshita M
    J Am Coll Cardiol; 2000 Nov; 36(5):1587-93. PubMed ID: 11079662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The regulation of plasma ketone body concentration by counterregulatory hormones in man.
    Schade DS; Eaton RP
    Diabetes; 1977 Oct; 26(10):989-96. PubMed ID: 908465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of neurohormonal activation and cardiopulmonary exercise testing in patients with chronic heart failure.
    Isnard R; Pousset F; Trochu J; Chafirovskaïa O; Carayon A; Golmard J; Lechat P; Thomas D; Bouhour J; Komajda M
    Am J Cardiol; 2000 Aug; 86(4):417-21. PubMed ID: 10946035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of glucagon in enhancing ketone body production in ketotic diabetic man.
    Keller U; Schnell H; Sonnenberg GE; Gerber PP; Stauffacher W
    Diabetes; 1983 May; 32(5):387-91. PubMed ID: 6132846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure.
    Swan JW; Anker SD; Walton C; Godsland IF; Clark AL; Leyva F; Stevenson JC; Coats AJ
    J Am Coll Cardiol; 1997 Aug; 30(2):527-32. PubMed ID: 9247528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic control in diabetic pregnancy. Variations in plasma concentrations of glucose, free fatty acids, glycerol, ketone bodies, insulin, and human chorionic somatomammotropin during the last trimester.
    Persson B; Lunell NO
    Am J Obstet Gynecol; 1975 Jul; 122(6):737-45. PubMed ID: 1155514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulatory effect of norepinephrine on ketogenesis in normal and insulin-deficient humans.
    Keller U; Gerber PP; Stauffacher W
    Am J Physiol; 1984 Dec; 247(6 Pt 1):E732-9. PubMed ID: 6150642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diurnal variations in the concentrations of blood acetoacetate and 3-hydroxybutyrate. The ketone body peak around midnight and its relationship to free fatty acids, glycerol, insulin, growth hormone and glucose in serum and plasma.
    Wildenhoff KE; Johansen JP; Karstoft H; Yde H; Sorensen NS
    Acta Med Scand; 1974; 195(1-2):25-8. PubMed ID: 4817087
    [No Abstract]   [Full Text] [Related]  

  • 29. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia.
    Anker SD; Chua TP; Ponikowski P; Harrington D; Swan JW; Kox WJ; Poole-Wilson PA; Coats AJ
    Circulation; 1997 Jul; 96(2):526-34. PubMed ID: 9244221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of ketone bodies on basal and insulin-stimulated glucose utilization in man.
    Beylot M; Khalfallah Y; Riou JP; Cohen R; Normand S; Mornex R
    J Clin Endocrinol Metab; 1986 Jul; 63(1):9-15. PubMed ID: 3519651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.
    Tsutamoto T; Wada A; Maeda K; Hisanaga T; Maeda Y; Fukai D; Ohnishi M; Sugimoto Y; Kinoshita M
    Circulation; 1997 Jul; 96(2):509-16. PubMed ID: 9244219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ketone body turnover during and after exercise in overnight-fasted and starved humans.
    Féry F; Balasse EO
    Am J Physiol; 1983 Oct; 245(4):E318-25. PubMed ID: 6353933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in energy metabolite and regulatory hormone concentrations and net fluxes across splanchnic and peripheral tissues in fed and progressively fasted ewes.
    Heitmann RN; Sensenig SC; Reynolds CK; Fernandez JM; Dawes DJ
    J Nutr; 1986 Dec; 116(12):2516-24. PubMed ID: 3543261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucagon, insulin, growth hormone, and some blood metabolites during energy restriction ketonemia of lactating cows.
    de Boer G; Trenkle A; Young JW
    J Dairy Sci; 1985 Feb; 68(2):326-37. PubMed ID: 3886731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of ketonaemia in hyperthyroidism: study of the role of free fatty acids.
    Beylot M; Cohen R; Riou JP; Sautot G; Garcia I; Noel G; Mornex R
    Diabete Metab; 1983 Sep; 9(3):217-23. PubMed ID: 6360743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of glucose production and stimulation of insulin secretion by physiological concentrations of ketone bodies in man.
    Miles JM; Haymond MW; Gerich JE
    J Clin Endocrinol Metab; 1981 Jan; 52(1):34-7. PubMed ID: 7005257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal Changes in Circulating Ketone Body Levels in Patients With Acute Heart Failure: A Post Hoc Analysis of the EMPA-Response-AHF Trial.
    Voorrips SN; Boorsma EM; Beusekamp JC; DE-Boer RA; Connelly MA; Dullaart RPF; VAN-DER-Meer P; VAN-Veldhuisen DJ; Voors AA; Damman K; Westenbrink BD
    J Card Fail; 2023 Jan; 29(1):33-41. PubMed ID: 36244653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of alpha- and beta-receptors to ketogenic and lipolytic effects of norepinephrine in humans.
    Keller U; Weiss M; Stauffacher W
    Diabetes; 1989 Apr; 38(4):454-9. PubMed ID: 2538376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of exercise capacity to resting left ventricular performance and basal plasma norepinephrine levels in patients with congestive heart failure.
    Francis GS; Goldsmith SR; Cohn JN
    Am Heart J; 1982 Oct; 104(4 Pt 1):725-31. PubMed ID: 7124585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating erythropoietin levels and prognosis in patients with congestive heart failure: comparison with neurohormonal and inflammatory markers.
    George J; Patal S; Wexler D; Abashidze A; Shmilovich H; Barak T; Sheps D; Keren G
    Arch Intern Med; 2005 Jun; 165(11):1304-9. PubMed ID: 15956012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.